Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
ARR-002
product1 mentionslast seen Oct 13, 2026
A first-in-class MUC16/NaPi2b dual-target tetravalent antibody-drug conjugate for ovarian and endometrial cancer.
Relationships 5
- ARR-002applies toovarian cancer treatment95% confidence1 source
- ARR-002applies toendometrial cancer treatment95% confidence1 source
- ArriVent BioPharma, Inc.developsARR-00295% confidence1 source
- ARR-002composed ofantibody-drug conjugate93% confidence1 source
- Shanghai Allist Pharmaceuticals Co., Ltd.commercializesARR-00292% confidence1 source
Relationship
ArriVent BioPharma, Inc.developsARR-002
95% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1